Expression of interleukin-6 is suppressed by inhibition of voltage-sensitive Na+/Ca2+ channels after cerebral ischemia

NeuroReport

Volumn 11, Issue 11, 2000, Pages 2565-2569

  Suzuki, Shigeaki ^a   Tanaka, Kortaro ^a   Nogawa, Shigeru ^a   Dembo, Tomohisa ^a   Kosakai, Arifumi ^a   Fukuuchi, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Ca2+ channel; Cerebral ischemia; Immunohistochemistry; Interleukin 6; Rat

Indexed keywords

4 (4 FLUOROPHENYL) 2 METHYL 6 (5 PIPERIDINOPENTYLOXY)PYRIMIDINE; 4 (4 FLUOROPHENYL) 2 METHYL 6 (5 PIPERIDINOPHETYLOXY)PYRIMIDINE; CALCIUM CHANNEL BLOCKING AGENT; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM CALCIUM EXCHANGE;

EID: 0034601368     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200008030-00043     Document Type: Article

References (25)

1. 1. Dirnagl U, Iadecola C and Moskowitz MA. Trends Neurosci 22, 391-397 (1999).
2. 2. Loddick SA, Turnbull AV and Rothwell NJ. J Cerebr Blood Flow Metab 18, 176-179 (1998).
3. 3. Londreth GE. Growth factors. In: Siegel GJ, ed. Basic Neurochemistry. Philadelphia: Lippincott-Raven; 1999, pp. 383-398.
4. 4. Tarkowski E, Rosengran L, Blomstrand C et al. Stroke 26, 1393-1398 (1995).
5. 5. Suzuki S, Tanaka K, Nagata E et al. Neurosci Lett 262, 117-120 (1999).
6. 6. Suzuki S, Tanaka K, Nogawa S et al. J Cerebr Blood Flow Metab 19, 1256-1262 (1999).
7. 7. Van Wagoner NJ and Benveniste EN. J Neuroimmunol 100, 124-139 (1999).
8. 8. Suma C, Hayashi S, Ukai Y et al. Eur J Pharmacol 336, 283-290 (1997).
9. 9. Takagaki Y, Itoh Y, Aoki Y et al. J Neurochem 68, 2507-2513 (1997).
10. 10. Koizumi J, Yoshida Y, Nakazawa T et al. Jpn J Stroke 8, 1-8 (1986).
11. 11. Belayev L, Alonso OF, Busto R et al. Stroke 27, 1616-1623 (1996).
12. 12. Bederson JB, Pitts LH, Tsuji M et al. Stroke 17, 472-476 (1986).
13. 13. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press; 1986.
14. 14. Streit WJ and Kreutzberg GW. J Neurocytol 16, 249-260 (1987).
15. 15. Kristian T and Siesjo BK. Stroke 29, 705-718 (1998).
16. 16. Kobayashi T and Mori Y. Eur P Pharmacol 363, 1-15 (1998).
17. 17. Itoh Y, Oka M, Ukai Y et al. Neurosci Lett 252, 203-206 (1998).
18. 18. Itoh Y, Aoki Y, Nonaka K et al. Life Sci 61, 957-966 (1997).
19. 19. Sawada M, Suzumura A and Marunouchi T. Brain Res 583, 296-299 (1992).
20. 20. Van Wagoner NJ, Oh JW, Repovic P et al. J Neurosci 19, 5236-5244 (1999).
21. 21. Schwaninger M, Neher M, Viegas E et al. J Neurochem 69, 1145-1150 (1997).
22. 22. Hans VHJ, Kossmann T, Lenzlinger PM et al. J Cerebr Blood Flow Metab 19, 184-194 (1999).
23. 23. Rodler S, Roth M, Nauck M et al. J Mol Cell Cardiol 27, 2295-2302 (1995).
24. 24. Eickelberg O, Roth M, Mussmann R et al. Circulation 99, 2276-2282 (1999).
25. 25. Gaumond F, Fortin D, Stankova J et al. J Cardivasc Pharmacol 30, 169-175 (1997).